Literature DB >> 25434636

Invasion of uterine cervical squamous cell carcinoma cells is facilitated by locoregional interaction with cancer-associated fibroblasts via activating transforming growth factor-beta.

Michikazu Nagura1, Noriomi Matsumura1, Tsukasa Baba2, Ryusuke Murakami1, Budiman Kharma1, Junzo Hamanishi1, Ken Yamaguchi1, Kaoru Abiko1, Masafumi Koshiyama1, Masaki Mandai3, Takuya Murata4, Susan K Murphy5, Ikuo Konishi1.   

Abstract

OBJECTIVE: Local invasion is a common pattern of spread in uterine cervical squamous cell carcinoma (CSCC). Although transforming growth factor-beta (TGF-β) facilitates invasion of various types of cancer cells, the role of the TGF-β pathway in CSCC is unclear. In this study, we analyzed the role of TGF-β signaling in the progression of CSCC.
METHODS: Immunohistochemistry was used to examine the expression of TGF-β pathway molecules in 67 CSCC samples with clinicopathological data. Activation of the TGF-β pathway was investigated following co-culture of CSCC cells and cervical cancer-associated fibroblasts (CCAFs).
RESULTS: Clinicopathological analysis of CSCC samples revealed that prominent expression of TGF-β receptor-2 was more frequent in CSCC with lymphovascular space invasion (LVSI) than without LVSI (p < 0.01). Lymph node metastasis was more frequent in cases in which phosphorylated SMAD3 (pSMAD3) was localized exclusively at the boundary of tumor clusters (n = 9, p < 0.05). Recombinant TGF-β1 increased pSMAD3 expression and enhanced cellular invasion (p < 0.005) in CSCC cells, which was attenuated by an inhibitor of the TGF-β receptor (p < 0.005). Enhanced pSMAD3 expression and invasion was also observed when conditioned media from CSCC cells co-cultured with CCAFs were administered. Luciferase assays showed that this medium contained a large amount of active TGF-β. Along with TGF-β activation, thrombospondin-1 was upregulated in both CSCC cells and CCAFs, while thrombospondin-1 silencing in either CSCC cells or CCAFs repressed the activity of TGF-β. Thrombospondin-1 was prominently expressed in cases with pSMAD3 boundary staining (p < 0.05).
CONCLUSIONS: These results suggest that interaction between CSCC cells and surrounding CCAFs activates TGF-β via thrombospondin-1 secretion to facilitate CSCC invasion.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer associated fibroblasts; Cervical cancer; Invasion; TGF-beta

Mesh:

Substances:

Year:  2014        PMID: 25434636     DOI: 10.1016/j.ygyno.2014.11.075

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  9 in total

Review 1.  Transforming growth factor-β1 in carcinogenesis, progression, and therapy in cervical cancer.

Authors:  Haiyan Zhu; Hui Luo; Zhaojun Shen; Xiaoli Hu; Luzhe Sun; Xueqiong Zhu
Journal:  Tumour Biol       Date:  2016-03-24

Review 2.  The Interaction Between Human Papillomaviruses and the Stromal Microenvironment.

Authors:  B Woodby; M Scott; J Bodily
Journal:  Prog Mol Biol Transl Sci       Date:  2016-10-11       Impact factor: 3.622

Review 3.  CAF cellular glycolysis: linking cancer cells with the microenvironment.

Authors:  Amrita Roy; Soumen Bera
Journal:  Tumour Biol       Date:  2016-04-13

4.  MiR-519d facilitates the progression and metastasis of cervical cancer through direct targeting Smad7.

Authors:  Jue-Yu Zhou; Si-Rong Zheng; Jie Liu; Rong Shi; Hai-Lang Yu; Min Wei
Journal:  Cancer Cell Int       Date:  2016-03-22       Impact factor: 5.722

5.  MicroRNA-106b is involved in transforming growth factor β1-induced cell migration by targeting disabled homolog 2 in cervical carcinoma.

Authors:  Yuan Cheng; Yanli Guo; Youyi Zhang; Ke You; Zijian Li; Li Geng
Journal:  J Exp Clin Cancer Res       Date:  2016-01-15

6.  MicroRNA-221-3p, a TWIST2 target, promotes cervical cancer metastasis by directly targeting THBS2.

Authors:  Wen-Fei Wei; Chen-Fei Zhou; Xiang-Guang Wu; Li-Na He; Lan-Fang Wu; Xiao-Jing Chen; Rui-Ming Yan; Mei Zhong; Yan-Hong Yu; Li Liang; Wei Wang
Journal:  Cell Death Dis       Date:  2017-12-14       Impact factor: 8.469

Review 7.  On-Target Anti-TGF-β Therapies Are Not Succeeding in Clinical Cancer Treatments: What Are Remaining Challenges?

Authors:  Adilson Fonseca Teixeira; Peter Ten Dijke; Hong-Jian Zhu
Journal:  Front Cell Dev Biol       Date:  2020-07-08

8.  Six-lncRNA Immune Prognostic Signature for Cervical Cancer.

Authors:  Qian Chen; Lang Hu; Dongping Huang; Kaihua Chen; Xiaoqiang Qiu; Bingqing Qiu
Journal:  Front Genet       Date:  2020-10-14       Impact factor: 4.599

9.  The Newly Synthetized Chalcone L1 Is Involved in the Cell Growth Inhibition, Induction of Apoptosis and Suppression of Epithelial-to-Mesenchymal Transition of HeLa Cells.

Authors:  Tomas Kuruc; Martin Kello; Klaudia Petrova; Zuzana Kudlickova; Peter Kubatka; Jan Mojzis
Journal:  Molecules       Date:  2021-03-03       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.